These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8053282)

  • 41. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol.
    González Maqueda I
    Coron Artery Dis; 1994 Nov; 5(11):909-18. PubMed ID: 7719523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
    Magliano MF; Amodeo C; Mion Júnior D; Francischetti E; Lima Júnior E; Nobre F; Chaves H; Ribeiro JM; Spritzer N; Jardim PC
    Arq Bras Cardiol; 1993 Nov; 61(5):311-8. PubMed ID: 8147731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of carvedilol or amlodipine on target organ damage in L-NAME hypertensive rats: their relationship with blood pressure variability.
    Del Mauro JS; Prince PD; Donato M; Fernandez Machulsky N; Morettón MA; González GE; Bertera FM; Carranza A; Gorzalczany SB; Chiappetta DA; Berg G; Morales C; Gelpi RJ; Taira CA; Höcht C
    J Am Soc Hypertens; 2017 Apr; 11(4):227-240. PubMed ID: 28595719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The once-daily dose regimen of carvedilol: a meta-analysis approach.
    Stienen U
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S128-33. PubMed ID: 1378140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood pressure lowering and cerebral blood flow: a comparison of the effects of carvedilol and propranolol on the cerebral circulation in hypertensive patients.
    James IM; Yogendran L; McLaughlin K; Munro C
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S40-3. PubMed ID: 1378148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
    Dupont AG; Van der Niepen P; Taeymans Y; Ingels M; Piepsz A; Bossuyt AM; Block P; Six RO; Jonckheer MH; Vanhaelst L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S130-6. PubMed ID: 2454359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparative study of carvedilol, slow-release nifedipine, and atenolol in the management of essential hypertension.
    Hall S; Prescott RI; Hallman RJ; Dixon S; Harvey RE; Ball SG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S35-8. PubMed ID: 1721977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose-effect relationship of carvedilol in essential hypertension. An open study.
    Ogihara T; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T; Arakawa K
    Drugs; 1988; 36 Suppl 6():75-81. PubMed ID: 2908305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carvedilol in hypertension.
    Raftery EB
    Cardiology; 1993; 82 Suppl 3():40-4. PubMed ID: 8106164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy of native carvedilol in patients with essential hypertension].
    Yang T; Zhang Z; Jia Z; Lin S; Peng Y
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):153-6. PubMed ID: 11938776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antihypertensive effect of carvedilol: a preliminary dose-response study.
    Casadei B; Conway J; Coats AJ; Bird R
    Clin Investig; 1992; 70 Suppl 1():S37-8. PubMed ID: 1350482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Follow-up of a method of twenty-four-hour indirect blood pressure monitoring: evaluation of carvedilol, a new antihypertensive agent.
    Meyer-Sabellek W; Schulte KL; Distler A; Gotzen R
    Nephron; 1987; 47 Suppl 1():42-6. PubMed ID: 3320788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
    Rouleau JL; Roecker EB; Tendera M; Mohacsi P; Krum H; Katus HA; Fowler MB; Coats AJ; Castaigne A; Scherhag A; Holcslaw TL; Packer M;
    J Am Coll Cardiol; 2004 Apr; 43(8):1423-9. PubMed ID: 15093878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.